Xenon Pharmaceuticals Investor Relations Material
Latest events
Q2 2025
Xenon Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Xenon Pharmaceuticals Inc
Access all reports
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for neurological disorders. The company leverages its expertise in ion channel biology to advance a pipeline of small-molecule therapies aimed at treating conditions such as epilepsy, rare neurological diseases, and other central nervous system disorders. The company is headquartered in Burnaby, Canada, and its shares are listed on the NASDAQ.
Key slides for Xenon Pharmaceuticals Inc
Corporate Presentation
Xenon Pharmaceuticals Inc
Corporate Presentation
Xenon Pharmaceuticals Inc
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
XENE
Country
🇺🇸 United States